Open Call HORIZON-MISS-2022-CANCER-01-04: Towards the creation of a European Cancer Patient Digital Centre

European Commission The overall goal of the Mission on Cancer[1] and the Europe’s Beating Cancer Plan[2] includes a better quality of life for patients and their families living with, and after, cancer.

Project results will support the creation of a virtual European Cancer Patient Digital Centre (ECPDC), which is a federated network of patient controlled (national) health data infrastructures enabling the voluntary exchange of patients and survivors' health data in a standardised approach, for primary and secondary use.

To that end, proposals under this topic should aim for delivering results that are directed, tailored towards and contributing to all of the following expected outcomes:

  • Citizens, including cancer patients and survivors, are able to donate, access and manage their own clinical data, including patient-reported outcomes (PRO), and have control over the access to these data in a secure, standardised, ethical and interoperable manner.
  • Citizens, including cancer patients and survivors, their families and caregivers have access to and use the ECPDC as a global centre of knowledge on cancer, including on prevention, diagnosis, treatment guidelines, treatment side-effects, access to cross-border health care, psychosocial and legal support, including guidance and support on returning to work, addressing financial issues and asserting survivors’ rights.
  • Tools are provided to clinicians allowing them to collaborate with patients to develop the best methods of care and personalized treatments regardless of their location.
  • Citizens, including cancer patients and survivors, receive information on personalised care through the ECPDC, which monitors data trends and provide insights on treatment side effects and other outcome measures based on standardised patient-reported outcome and experience measures, by aggregating and analysing large data sets using state-of-the-art secure cloud computing and data analytics and visualisation methods and tools, including AI.
  • Citizens, including cancer patients and survivors, are empowered in co-deciding on their care as well as in participating in research. The rights of patients are reinforced and their confidence in sharing their data for cancer research, innovation and policy development is increased.
  • Researchers, citizens, including cancer patients and survivors, and policy-makers have access to a valuable resource of aggregated patient data that are evolving over time, to correlate different sources of information and whereby disease trajectories of patient’s and survivor’s health could be inferred. This will improve the knowledge and understanding of cancer and its impact on the lives of citizens, including cancer patients and survivors, thus contributing to the development of improved diagnostics, treatment, care and quality of life support and to the development of policies.

Scope

Patient-controlled health data networks in Europe show a high level of heterogeneity with regard to the involvement of EU Member States, as well as the types and interoperability of collected data, organisation and governance of data storage, its access and security, and the possibility to reuse data for research purposes.

Proposals should address the existing challenges and develop a roadmap towards the creation of the ECPDC as a virtual, federated network of national infrastructures of patient-controlled health data (‘national or regional nodes’), taking into account synergies with the future UNCAN.eu platform, integrated within a larger European network of infrastructures, to which each Member State should have a single access portal.

The proposals should draw on existing expertise at the EU[3] and national level and on EU- and Member State/Associated Country-tailored procedures for access, use and re-use of patient data. Moreover, synergies with the European Network of Cancer Registries[4] should be established to ensure the ECPDC will create an ecosystem on knowledge of cancer. It could also include a call centre function.

In particular, proposals should take account of the results of a recently launched call on a pilot project for an EU infrastructure ecosystem for the secondary use of health data for research, policy-making and regulatory purposes[5], the future EU legislation on European Health Data Space (EHDS)[6], the future Cancer Survivor Smart-Card[7], the cancer use case under the 1+Million Genomes initiative (1+MG)[8], the Cancer Imaging Initiative[9] as well as the European Open Science Cloud[10]. Successful applicants will be asked to liaise with these different initiatives where applicable[11], with the Commission acting as a facilitator.

Accordingly, proposals should cover all of the following activities:

  • Actively engage and facilitate assessment of relevant existing patient-controlled health data networks at the EU and Member State/Associated Country level, to assess how the ECPDC will integrate and interact with existing national care pathways and the IT systems. A multidisciplinary team, including also users such as patients, care professionals and researchers, should be involved in the development of the proposed federated network.
  • Develop a roadmap outlining the necessary intermediate steps towards the creation of the federated network of national health data infrastructures, including technical requirements, governance aspects and timelines.
  • Design and perform a testing phase of the network before its release, allowing the adjustment of its tools/functionalities, validate the proposed approach and inform on how it could be scaled and sustained.
  • Analyse and provide solutions for extraction of health data, e.g. from the electronic health records, genomic databases (e.g. 1+MG)[8], the Cancer Imaging Initiative[9] and the future Cancer Survivor Smart-Card[14]. Data protection rules should be taken into account.
  • Analyse and provide solutions for cross-border transfer of personal data and options to access and store patient data, taking into account the eIDAS, GDPR, other EU and national legislations, and the integration of the ECPDC within the European Health Data Space.
  • Establish robust communication and effective information exchange between diverse actors such as cancer patients and survivors, formal and informal caregivers, policy makers and researchers.
  • The funded actions should build upon resources made available by the Knowledge Centre on Cancer[15], and complement actions under the Europe’s Beating Cancer Plan[16], including the Cancer Imaging Initiative[17], and the future European Health Data Space[18].

Furthermore, all projects funded under this topic are strongly encouraged to participate in networking and joint activities with other ongoing projects under the mission on cancer (especially with UNCAN.eu) and other cancer relevant projects, as appropriate. These networking and joint activities could, for example, involve the participation in joint workshops, the exchange of knowledge, the development and adoption of best practices, or joint communication activities. This could also involve networking and joint activities with projects funded under other clusters and pillars of Horizon Europe, or other EU programmes, as appropriate.

The Commission may facilitate Mission-specific coordination through future actions. Therefore, proposals should include a budget for the attendance to regular joint meetings and may consider covering the costs of any other potential joint activities without the prerequisite to detail concrete joint activities at this stage. The details of these joint activities will be defined during the grant agreement preparation phase and project duration. In this regard, the Commission will take on the role of facilitator for networking and exchanges, including with relevant initiatives and stakeholders, if appropriate.

Opening date: 24 May 2022

Deadline: 07 September 2022 17:00:00 Brussels time

Deadline Model: single-stage

Type of action: HORIZON-CSA HORIZON Coordination and Support Actions

For topic conditions, documents and submission service, please visit:
https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-miss-2022-cancer-01-04

1. https://ec.europa.eu/info/publications/implementation-plans-eu-missions_en
2. https://ec.europa.eu/health/system/files/2021-02/eu_cancer-plan_en_0.pdf
3. https://tehdas.eu
4. https://www.encr.eu
5. Funding & tenders (europa.eu)
6. Future EC proposal on the use of data for healthcare and re-use of data for policymaking, regulatory purposes and research, to be adopted in 2022
7. As published on the Funding & Tenders Portal
8. 1+ Million Genomes | Shaping Europe’s digital future (europa.eu)
9. Funding & tenders (europa.eu)
10. https://ec.europa.eu/info/research-and-innovation/strategy/strategy-2020-2024/our-digital-future/open-science/european-open-science-cloud-eosc_en
11. Applicants are not expected to contact these initiatives before the submission of proposals
12. 1+ Million Genomes | Shaping Europe's digital future (europa.eu)
13. Funding & tenders (europa.eu)
14. Funding & tenders (europa.eu)
15. Especially through the ’European Cancer Information System (ECIS)’, see https://knowledge4policy.ec.europa.eu/cancer_en
16. Including the planned Cancer Inequalities Registry, see work programme for 2021 for EU4Health Programme at: https://ec.europa.eu/health/sites/default/files/funding/docs/wp2021_annex_en.pdf.
17. Funding & tenders (europa.eu)
18. https://ec.europa.eu/health/ehealth-digital-health-and-care/european-health-data-space_en

Most Popular Now

Transforming Drug Discovery with AI

A new AI-powered program will allow researchers to level up their drug discovery efforts. The program, called TopoFormer, was developed by an interdisciplinary team led by Guowei Wei, a Michigan...

We may Soon be Able to Detect Cancer wit…

A new paper in Biology Methods & Protocols, published by Oxford University Press, indicates that it may soon be possible for doctors to use artificial intelligence (AI) to detect and...

Maternity Tech Launched to Help NHS Meas…

Health tech provider C2-Ai has formally launched a new 'observatory' system to help hospitals gain a better understanding of risks, outcomes and safety within maternity and neonatal services. Announced at the...

Large Language Models Illuminate a Progr…

This study is led by Prof. Bin Dong (Beijing International Center for Mathematical Research, Peking University) and Prof. Lin Shen (Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational...

Health Innovation East Partners with Cog…

Health Innovation East, the innovation arm of the NHS in the East of England and Cogniss, a no-code ecosystem for digital health solutions, have announced a strategic partnership to launch...

An AI-Powered Wearable System Tracks the…

Scientists at the University of Southern California have developed an artificial intelligence (AI)-powered system to track tiny devices that monitor markers of disease in the gut. Devices using the novel...

"Self-Taught" AI Tool Helps to…

A computer program based on data from nearly a half-million tissue images and powered by artificial intelligence (AI) can accurately diagnose cases of adenocarcinoma, the most common form of lung...

New Computational Model of Real Neurons …

Nearly all the neural networks that power modern artificial intelligence (AI) tools such as ChatGPT are based on a 1960s-era computational model of a living neuron. A new model developed...

Meet CARMEN, a Robot that Helps People w…

Meet CARMEN, short for Cognitively Assistive Robot for Motivation and Neurorehabilitation - a small, tabletop robot designed to help people with mild cognitive impairment (MCI) learn skills to improve memory...

AI Matches Protein Interaction Partners

Proteins are the building blocks of life, involved in virtually every biological process. Understanding how proteins interact with each other is crucial for deciphering the complexities of cellular functions, and...

AI Model to Improve Patient Response to …

A new artificial intelligence (AI) tool that can help to select the most suitable treatment for cancer patients has been developed by researchers at The Australian National University (ANU). DeepPT, developed...

Mobile Phone Data Helps Track Pathogen S…

A new way to map the spread and evolution of pathogens, and their responses to vaccines and antibiotics, will provide key insights to help predict and prevent future outbreaks. The...